ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.322,59
0,91%
S&P 500
5.969,34
0,35%
Dow Jones
44.296,51
0,97%
Euro vs US Dollar
1,0418
0,00%
Bitcoin
98.339,17
0,57%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Kanada
  5. TSXV

  6. Acasti Pharma Inc (ACST) Börsenkurse

Acasti Pharma Inc

Acasti Pharma Inc (ACST)

Acasti Pharma Inc
0,58
0,00
(0,00%)
Geschlossen 24 November 10:00PM
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
0,58
Gebot
0,58
Fragen
0,98
Volumen
-
0,00 Tagesbereich 0,00
0,58 52-Wochen-Bereich 0,58
Marktkapitalisierung
5,451M
Handelsende
0,58
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
9.399.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,46
Gewinn pro Aktie (EPS)
-1,37
Erlöse
-
Nettogewinn
-12,85M

Über Acasti Pharma Inc

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.acastipharma.com
Hauptsitz
Jersey City, New Jersey, USA
Gegründet
-
Acasti Pharma Inc is listed in the Pharmaceutical Preparations sector of the TSX Venture Börse with ticker ACST. The last closing price for Acasti Pharma was $0,58. Over the last year, Acasti Pharma shares have traded in a share price range of $ 0,58 to $ 0,58.

Acasti Pharma currently has 9.399.000 shares in issue. The market capitalisation of Acasti Pharma is $5,45 million. Acasti Pharma has a price to earnings ratio (PE ratio) of -2.46.

ACST Neueste Nachrichten

Weitere Nachrichten

Acasti Pharma Reports Third Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

14 Februar 2023
GlobeNewswire Inc.

Acasti Receives Extension to Regain Compliance with NASDAQ Minimum Bid Price Rule

LAVAL, Québec, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

25 Januar 2023
GlobeNewswire Inc.

Acasti Pharma to Present at Lytham Partners Investor Select Conference on January 31

LAVAL, Québec, Jan. 24, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

24 Januar 2023
GlobeNewswire Inc.

Acasti Pharma to Present at Sidoti Virtual Investor Conference on January 18

LAVAL, Québec, Jan. 13, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

13 Januar 2023
GlobeNewswire Inc.

Acasti to Host Conference Call on Tuesday, January 10, 2023 to Discuss Results from Recent Phase 1 PK Studies for GTX-101 and GTX-102 That Met All Outcome Measures

LAVAL, Québec, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

05 Januar 2023
GlobeNewswire Inc.

Acasti Announces Preliminary Topline Results Met All Outcome Measures in the Pharmacokinetic Bridging Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia

LAVAL, Québec, Dec. 28, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

28 Dezember 2022
GlobeNewswire Inc.

Acasti Pharma Announces Preliminary Topline Results Met All Primary Outcome Measures in the Single Dose Pharmacokinetic Study for GTX-101, the Company’s Drug Candidate for the Treatment of Postherpetic Neuralgia (PHN)

LAVAL, Québec, Dec. 22, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

22 Dezember 2022
GlobeNewswire Inc.

Acasti Pharma Reports Second Quarter 2023 Operational Results

Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a...

14 November 2022
GlobeNewswire Inc.

Acasti Pharma to Present at Q4 Investor Summit

LAVAL, Québec, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three...

09 November 2022
GlobeNewswire Inc.

Acasti Pharma to Report Second Quarter 2023 Financial Results on Monday, November 14, 2022

LAVAL, Quebec, Nov. 07, 2022 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical...

07 November 2022
GlobeNewswire Inc.
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.580.580.5800CS
4000.580.580.5800CS
12000.580.580.5800CS
26000.580.580.5800CS
52000.580.580.5800CS
156-1.29-68.98395721931.872.30.4739441.50324433CS
260-2.29-79.79094076662.874.050.221083660.90475181CS

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
GNFIGenifi Inc
$ 0,015
(200,00%)
154k
AVII.PAntera Ventures II Corp
$ 0,07
(180,00%)
1.000
MVYMoovly Media Inc
$ 0,01
(100,00%)
6,36k
CYFCanyon Creek Food Company Ltd
$ 0,025
(66,67%)
2k
SEVSpectra7 Microsystems Inc
$ 0,185
(54,17%)
284,14k
SSESilver Spruce Resources Inc
$ 0,005
(-50,00%)
40,31k
TVC.HThree Valley Copper Corp
$ 0,005
(-50,00%)
218k
CCDCascadero Copper Corporation
$ 0,005
(-50,00%)
7k
EKGCardioComm Solutions Inc
$ 0,005
(-50,00%)
257k
KLXCarbon Done Right Developments Inc
$ 0,01
(-33,33%)
412k
TVITVI Pacific Inc
$ 0,01
(0,00%)
9,25M
DMDataMetrex AI Limited
$ 0,005
(0,00%)
5,09M
DMGIDMG Blockchain Solutions Inc
$ 0,435
(6,10%)
3,16M
FUUF3 Uranium Corp
$ 0,235
(0,00%)
3,09M
THRMTherma Bright Inc
$ 0,025
(0,00%)
2,53M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

TSXV
ACST
Acasti Pharma
COIN
ESSGBP
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten